Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
International Journal of Cancer
|
November 16, 2005
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
Xabier Agirre, José Román-Gómez, Iria Vázquez, et al.
Scientific Reports
|
November 1, 2017
In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer
Jon Pey, Edurne San José-Eneriz, María Carmen Ochoa, et al.
Nature Communications
|
October 11, 2024
An automated network-based tool to search for metabolic vulnerabilities in cancer
Luis V Valcárcel, Edurne San José-Enériz, Raquel Ordoñez, et al.
Plos One
|
December 28, 2017
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome
Juan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, et al.
Stem Cell Reports
|
December 23, 2022
Revealing cell populations catching the early stages of human embryo development in naive pluripotent stem cell cultures
Marta Moya-Jódar, Asier Ullate-Agote, Paula Barlabé, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Plos One
|
March 10, 2011
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia
Amaia Vilas-Zornoza, Xabier Agirre, Vanesa Martín-Palanco, et al.
Plos One
|
February 14, 2012
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
Cristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, et al.
Molecular Cancer Research : MCR
|
December 17, 2008
Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth
Xabier Agirre, Antonio Jiménez-Velasco, Edurne San José-Enériz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
International Journal of Cancer
|
November 16, 2005
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
Xabier Agirre, José Román-Gómez, Iria Vázquez, et al.
Scientific Reports
|
November 1, 2017
In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer
Jon Pey, Edurne San José-Eneriz, María Carmen Ochoa, et al.
Nature Communications
|
October 11, 2024
An automated network-based tool to search for metabolic vulnerabilities in cancer
Luis V Valcárcel, Edurne San José-Enériz, Raquel Ordoñez, et al.
Plos One
|
December 28, 2017
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome
Juan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, et al.
Stem Cell Reports
|
December 23, 2022
Revealing cell populations catching the early stages of human embryo development in naive pluripotent stem cell cultures
Marta Moya-Jódar, Asier Ullate-Agote, Paula Barlabé, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Plos One
|
March 10, 2011
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia
Amaia Vilas-Zornoza, Xabier Agirre, Vanesa Martín-Palanco, et al.
Plos One
|
February 14, 2012
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
Cristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, et al.
Molecular Cancer Research : MCR
|
December 17, 2008
Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth
Xabier Agirre, Antonio Jiménez-Velasco, Edurne San José-Enériz, et al.
Page
of 4